Steve Schonfeld’s Cellectis CLLS Stock Holding History

Steve Schonfeld’s Portfolio CLLS Stock Details CLLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-14,400	Closed	-$239K	–	1070
2018 Q4	$239K	Buy	+14,400	New	+$334K	0.01%	894

Other funds holding CLLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

Steve Schonfeld's CLLS Position: Q1 2019 in Review

Steve Schonfeld sold out of Cellectis (CLLS) in Q1 2019, closing a stake of 14,400 shares — an estimated $239K sold.

Steve Schonfeld first reported a position in CLLS in Q4 2018 and held it in 1 quarter. The position peaked at $239K in Q4 2018. 63 funds tracked by Wall St. Rank hold CLLS as of Q1 2019.

Steve Schonfeld reported no remaining Cellectis position as of Q1 2019 after selling out during the quarter.
Steve Schonfeld sold 14,400 Cellectis shares in Q1 2019, an estimated $239K.
Steve Schonfeld first reported a position in Cellectis in Q4 2018 and held it in 1 quarter.
Steve Schonfeld's Cellectis position peaked at $239K in Q4 2018.
63 funds tracked by Wall St. Rank held Cellectis as of Q1 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2019, filed 15 May 2019.